Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic comparison of Dabigatran with water vs thickened water in healthy adults
jRCTs031250724Phase 1Recruiting
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dabigatran in venous thromboembolism (VTE) and Atrial fibrillation (AFib). Primary endpoints: AUC0-24 and Cmax. Started Feb 2026; status: recruiting.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs031250724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250724.